PALI Palisade Bio, Inc.
Healthcare$1.99+2.05%ClosedMarket Cap: $345.4M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.21
P/S
0.00
EV/EBITDA
-7.75
DCF Value
$2.39
FCF Yield
-3.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-36.8%
ROA
-18.1%
ROIC
-20.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-10.7M | $-9.6M | $— | — |
| Q4 null | $0.00 | NaN% | $-10.0M | $-8.9M | $— | — |
| FY null | $0.00 | NaN% | $-18.1M | $-16.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-2.9M | $-2.9M | $— | — |
| Q2 null | $0.00 | NaN% | $-2.8M | $-2.8M | $— | — |
| Q1 null | $0.00 | NaN% | $-2.3M | $-2.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-3.4M | $-3.3M | $— | — |
| FY null | $0.00 | NaN% | $-14.9M | $-14.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-3.6M | $-3.5M | $— | — |
| Q2 null | $0.00 | NaN% | $-4.2M | $-4.1M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-3.7M | $-3.5M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-3.2M | $-3.0M | $-0.32 | — |